Mifepristone and misoprostol for early medical abortion: 18 Months experience in the United States

Contraception

Volumn 67, Issue 6, 2003, Pages 463-465

  Hausknecht, Richard ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Abortion complications; Medical abortion; Mifeprex; Mifepristone

Indexed keywords

DIPHENHYDRAMINE; MIFEPRISTONE; MISOPROSTOL;

ADULT; ALLERGIC REACTION; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CURETTAGE; ECTOPIC PREGNANCY; FOOD AND DRUG ADMINISTRATION; HEART INFARCTION; HEPATORENAL SYNDROME; HUMAN; NORMAL HUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; SIDE EFFECT; THERAPEUTIC ABORTION; UNITED STATES; VACUUM ASPIRATION; VAGINA BLEEDING;

EID: 0038176474     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(03)00049-0     Document Type: Article

References (14)

1. Ashok P.W., Penney G.C., Flett G.M., Templeton A. An effective regimen for early medical abortion a report of 2000 consecutive cases . Hum Reprod. 13:1998;2963-2965.
2. Peyron R., Aubeny E., Targoz V., et al. Early termination of pregnancy with mifepristone (RU 4876) and the orally active prostaglandin misoprostol. N Engl J Med. 328:1993;1509-1513.
3. Spitz I.M., Bardin C.W., Benton L., Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med. 338:1998;1241-1247.
4. Schaff E.A., Eisinger S.H., Stadalius L.S., Franks P., Gore B.Z., Poppema S. Low dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception. 59:1996;1-6.
5. Bartley J., Tong S., Everington D., Baird D.T. Parity is a major determinant of success rate in medical abortion a retrospective analysis of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost . Contraception. 62:2000;297-303.
6. Silvestre L., DuBois C., Renault M., Rezvani Y., Balieu E., Ulmann A. Voluntary interruption of pregnancy with mifepristone and a prostaglandin analogue. N Engl J Med. 322:1990;645-648.
7. Knudsen U.B. First trimester abortion with mifepristone and vaginal misoprostol. Contraception. 63:2000;247-250.
8. Allen R.H., Westhoff C., De Nonno L., Fielding S.L., Schaff E.A. Curettage after mifepristone induced abortion frequency, timing and indications . Obstet Gynecol. 98:2001;101-106.
9. Ulmann A., Silvestre L., Chemama L., et al. Medical termination of early pregnancy with mifepristone (RU486) followed by a prostaglandin analogue study in 16,369 women . Acta Obstet Gynecol Scand. 71:1992;278-283.
10. Paul M., Lichtenberg P., Borgatta L., Grimes D., Stubblefield P. A clinician's guide to medical and surgical abortion. 1998;Churchill Livingstone, New York.
11. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion a randomized trial . Br J Med. 107:2000;524-530.
12. Henshaw S.K., Finer L.B. The accessibility of abortion services in the United States, 2001. Perspect Sex Reprod Health. 35:2003;16-24.
13. Gonzalez C.H., Vargas R., Perez A.B., et al. Limb deficiency with or without Mobius sequence in seven Brazilian children associated with misoprostol use in the first trimester of pregnancy. Am J Med Genet. 47:1993;59-64.
14. Kaunitz A.M., Rovira E.Z., Grimes D.A., Schulz K.F. Abortions that fail. Obstet Gynecol. 66:1985;533-537.